Arrowhead Research Corp. (ARWR) Reports In-Line Q3 EPS, Provides Update on ARC-520
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Tesla acquires AI hardware company for up to $2 billion in stock
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
Arrowhead Research (ARWR) Sees Early Upside
August 14, 2014 9:44 AM EDTArrowhead Research (NASDAQ: ARWR) seeing strong morning upside on solid volume. Shares are up 7%.
Deutsche Bank Maintains Buy Rating on Arrowhead Research (ARWR)
August 13, 2014 9:58 AM EDTDeutsche Bank maintained a Buy rating on Arrowhead Research (NASDAQ: ARWR) with a price target of $45. Comments follow its ARC-520 update.
Analyst Alethia Young said, "We feel more confident in ARC-520 and their platform technology after this interim update. Safety looks solid... More
Arrowhead Research (ARWR) Bullish Stance Reiterated at Jefferies as ARC-520 Shows Highly Encouraging Efficacy
August 13, 2014 6:52 AM EDTJefferies analyst Thomas Wei reiterated a Buy rating and $30 price target on Arrowhead Research (NASDAQ: ARWR) as ARC-520 shows highly encouraging efficacy.
Wei commented, "ARWR provided an update from its Phase 2a trial, in which patients receiving a single dose of ARC-520... More
